OSE IMMUNOTHERAPEUTICSOSE IMMUNOTHERAPEUTICSOSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

No trades
See on Supercharts
Market capitalization
‪108.68 M‬EUR
−1.175EUR
‪−23.00 M‬EUR
‪2.23 M‬EUR
‪15.52 M‬
Beta (1Y)
0.98

About OSE IMMUNOTHERAPEUTICS

CEO
Nicolas Poirier
Headquarters
Nantes
Founded
2004
ISIN
FR0012127173
FIGI
BBG008891XD6
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OSE is 5.380 EUR — it has increased by 7.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange OSE IMMUNOTHERAPEUTICS stocks are traded under the ticker OSE.
OSE IMMUNOTHERAPEUTICS is going to release the next earnings report on Sep 26, 2024. Keep track of upcoming events with our Earnings Calendar.
OSE stock is 10.91% volatile and has beta coefficient of 0.98. Check out the list of the most volatile stocks — is OSE IMMUNOTHERAPEUTICS there?
One year price forecast for OSE IMMUNOTHERAPEUTICS has a max estimate of 10.000 EUR and a min estimate of 7.000 EUR.
OSE earnings for the last quarter are −0.64 EUR per share, whereas the estimation was 0.15 EUR resulting in a −526.67% surprise. The estimated earnings for the next quarter are −0.33 EUR per share. See more details about OSE IMMUNOTHERAPEUTICS earnings.
OSE IMMUNOTHERAPEUTICS revenue for the last quarter amounts to ‪8.98 M‬ EUR despite the estimated figure of ‪12.20 M‬ EUR. In the next quarter revenue is expected to reach ‪12.30 M‬ EUR.
Yes, you can track OSE IMMUNOTHERAPEUTICS financials in yearly and quarterly reports right on TradingView.
OSE stock has risen by 14.35% compared to the previous week, the month change is a 15.45% rise, over the last year OSE IMMUNOTHERAPEUTICS has showed a 9.80% increase.
OSE net income for the last quarter is ‪−11.14 M‬ EUR, while the quarter before that showed ‪−11.86 M‬ EUR of net income which accounts for 6.05% change. Track more OSE IMMUNOTHERAPEUTICS financial stats to get the full picture.
Today OSE IMMUNOTHERAPEUTICS has the market capitalization of ‪108.54 M‬, it has decreased by 1.03% over the last week.
No, OSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OSE IMMUNOTHERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
OSE reached its all-time high on Feb 22, 2021 with the price of 15.800 EUR, and its all-time low was 2.700 EUR and was reached on Dec 21, 2018.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OSE IMMUNOTHERAPEUTICS technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OSE IMMUNOTHERAPEUTICS stock shows the neutral signal. See more of OSE IMMUNOTHERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OSE IMMUNOTHERAPEUTICS future price: according to them, OSE price has a max estimate of 10.00 EUR and a min estimate of 7.00 EUR. Read a more detailed OSE IMMUNOTHERAPEUTICS forecast: see what analysts think of OSE IMMUNOTHERAPEUTICS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OSE IMMUNOTHERAPEUTICS EBITDA is ‪−28.61 M‬ EUR, and current EBITDA margin is ‪−1.14 K‬%. See more stats in OSE IMMUNOTHERAPEUTICS financial statements.